DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, also known as double-hit lymphoma, has been reported as refractory to R-CHOP therapy and requires more intensive regimens. However, intensive and safe regimens for patients with renal dysfunction are unknown. Herein, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitobe, Masaki, Kawamoto, Keisuke, Suzuki, Takaharu, Suwabe, Tatsuya, Shibasaki, Yasuhiko, Masuko, Masayoshi, Inoue, Kanako, Miyoshi, Hiroaki, Ohshima, Koichi, Sone, Hirohito, Takizawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053571/
https://www.ncbi.nlm.nih.gov/pubmed/33551436
http://dx.doi.org/10.3960/jslrt.20043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053571/
https://www.ncbi.nlm.nih.gov/pubmed/33551436
http://dx.doi.org/10.3960/jslrt.20043

Ejemplares similares